-
Mashup Score: 0
Measurable residual disease (MRD) has become a key biomarker in the field of multiple myeloma (MM), and the sensitivity of…
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0#mmMRD - Healthcare Social Media Analytics and Transcripts - 8 month(s) ago
What is #mmMRD? measurable residual disease, minimal residual disease, Multiple Myeloma. Healthcare Social Media Hashtag. Real-time Analytics.
Source: www.symplur.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Top Influencers of #mmMRD 👉 @DoctorAKrishnan @Phari @Myeloma_Doc @bdermanmd @SWOG @LynneWagnerPhD https://t.co/XYlPArAZD1 via @symplur
-
-
Mashup Score: 1Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma - 8 month(s) ago
Blood Cancer Journal – Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] @bdermanmd @ajjakubowiak @mtmdphd @BloodCancerJnl https://t.co/oioEadi46u #mmMRD #mmsm #openaccess https://t.co/5NiTGtBVkS
-
-
Mashup Score: 0Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial - Full Text View - ClinicalTrials.gov - 8 month(s) ago
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial – Full Text View.
Source: classic.clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= @myelomaMD https://t.co/qD26HMx3J8 #NCT04566328 #mmMRD #mmsm @eaonc @mweissmdphd @VincentRK @LynneWagnerPhD Wei Snyder Kostakoglu @mtmdphd https://t.co/hiixFYDWxO
-
-
Mashup Score: 0
Program: Oral and Poster Abstracts Session: 731. Clinical Autologous Transplantation: Results: Poster I Hematology Disease Topics & Pathways: Adult, Non-Biological, Therapies, Study Population, Clinically relevant Amrita Krishnan, MD 1, Antje Hoering, PhD 2, Parameswaran Hari, MBBS, MD 3, Rachael Sexton, PhD 2 * and Robert Z. Orlowski, MD, PhD 4 1 City of Hope Medical Center, Duarte, CA 2 SWOG Statistical Center, Seattle, WA 3 Division of Hematology and Oncology, Department of Medicine, Medical College of
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
. @SWOG S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease (#mmMRD) to direct Therapy Duration (DRAMMATIC) - @DoctorAKrishnan Hoering, @Phari Sexton, @Myeloma_Doc #ASH20 Abst 1515 https://t.co/IeLcOehWrr #NCT04071457 #mmsm https://t.co/IU4CIepx92
-
-
Mashup Score: 0Clinician attitudes and practices toward measurable residual disease in multiple myeloma - 8 month(s) ago
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol https://t.co/8zhxYfYwZQ #mmsm #mmMRD
-
-
Mashup Score: 0Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma - 8 month(s) ago
Blood Cancer Journal – Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] @bdermanmd @ajjakubowiak @mtmdphd @BloodCancerJnl https://t.co/oioEadhwgW #mmMRD #mmsm #openaccess https://t.co/hCnuRyJJdT
-
-
Mashup Score: 0#mmMRD - Healthcare Social Media Analytics and Transcripts - 8 month(s) ago
What is #mmMRD? measurable residual disease, minimal residual disease, Multiple Myeloma. Healthcare Social Media Hashtag. Real-time Analytics.
Source: www.symplur.comCategories: Hem/Oncs, Latest HeadlinesTweet-
#mmMRD healthcare social media hashtag [Nov 21, 2020] Minimal/measurable residual disease (MRD) in multiple myeloma. Submitted by @bdermanmd to @symplur @healthhashtags https://t.co/grkkiox2yh #mmsm
-
-
Mashup Score: 0Clinician attitudes and practices toward measurable residual disease in multiple myeloma - 8 month(s) ago
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol https://t.co/8zhxYfYwZQ #mmsm #mmMRD
-
-
Mashup Score: 0The clonoSEQ® Watch Registry - Full Text View - ClinicalTrials.gov - 8 month(s) ago
The clonoSEQ® Watch Registry – Full Text View.
Source: classic.clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Real World Observational Study Using Clonoseq® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry [Actual Study Start Date: Oct 13, 2020] PI = @JmPagelMD @AdaptiveBiotech https://t.co/XZKO6nFRjT #NCT04545333 #mmMRD #mmsm #ALLsm #CLLsm #lymsm
-
MRD has become a very important biomarker in multiple myeloma. Tune in to our podcast w/ @mbeksac56, @BrunoPaiva_UNAV & @End_myeloma, who discuss exciting applications of MRD in myeloma: 🎧 https://t.co/WGkOHOcmpa #MMsm #mmMRD #HemOnc https://t.co/r2MCWdtJVF